Results 91 to 100 of about 2,167,273 (278)

Targeted Nanomedicine to Treat Bone Metastasis

Pharmaceutics, 2018
Bone metastases are common complications of solid tumors, particularly those of the prostate, breast, and lungs. Bone metastases can lead to painful and devastating skeletal-related events (SREs), such as pathological fractures and nerve compressions ...
Isaac M. Adjei, Madison N. Temples, Shannon B. Brown, Blanka Sharma   +3 more
doaj   +1 more source

Nuclear medicine procedures and the evaluation of male sexual organs: a short review [PDF]

, 2008
Sexuality consists of three aspects that are interrelated and inseparable, biological, physiological and social. The biological aspect considers the individual's capability to give and to receive pleasure.
Adenilson de Souza da Fonseca, Bernardo-Filho M., Beutel M. E., Bouchelouche K., Chaffanjon P. C., Choe W., Dennerstein L., Fanti S., Ganjoo K. N., Gerber G., Halac M., Hatzimouratidis H., Jana S., Kevin Carter, Kim C. K., Kolodny R. C., Kotzerke J., Kotzerke J., Kumar V., Lange P. H., Mario Bernardo-Filho, Masters W. H., Orhan I., Perkins A., Perkins A., Ravizzini G., Roivainen A., Ryu J., Saha G., Sebastião David Santos-Filho, Shen Y. Y., Sotiris Missailidis, Stelzner F., Sumich A. L., Timmermans L., Tóth G., Valdés Olmos R. A., Warren G. P., Willan B. D., Zuckier L. S.   +39 more
core   +4 more sources

Diagnostic Strategies and Clinical Practice of Bone Marrow Metastases from Ewing Sarcoma

Zhongliu Fangzhi Yanjiu
Ewing sarcoma (EWS) is an invasive and primary bone tumor with a high incidence in children and adolescents. The presence and extent of metastases at the time of diagnosis remains the most important prognostic factor in determining a patient’s prognosis.
Wanru WANG, Yuhong ZHOU, Qin WANG, Jiaqi XIE, Baorui LIU, Rutian LI   +5 more
doaj   +1 more source

Treatment patterns and clinical outcomes in elderly patients with HER2-positive metastatic breast cancer from the registHER observational study. [PDF]

, 2012
Limited data exist regarding treatment patterns and outcomes in elderly patients with HER2-positive metastatic breast cancer (MBC). registHER is an observational study of patients (N = 1,001) with HER2-positive MBC diagnosed within 6 months of enrollment
Brufsky, Adam M, Feng, Shibao, Kaufman, Peter A, Mayer, Musa, Quah, Cheng S, Rugo, Hope S, Tripathy, Debu, Wang, Lisa I, Yardley, Denise A, Yood, Marianne Ulcickas   +9 more
core   +1 more source

Clinical Characteristics and Prognostic Factors in Bone Metastases from Lung Cancer

Medical Science Monitor, 2017
Background This study investigated the prognostic factors of bone metastases from lung cancer. Material/Methods From March 2014 to March 2015, 168 patients with bone metastases from lung cancer treated at our hospital were included and the clinical data ...
Li Zhang, Zhixin Gong
semanticscholar   +1 more source

Targeted Treatments of Bone Metastases in Patients with Lung Cancer

Frontiers in Oncology, 2014
Until now approximately 30-40% of patients with advanced lung cancer develop bone metastases, but as the newer therapies are extending survival, the chance of developing bone metastases increases.Bone metastases cause skeletal-related events (SREs) such ...
Vera eHirsh
doaj   +1 more source

A validation of the Oswestry Spinal Risk Index [PDF]

, 2016
Purpose The purpose of this study was to validate the Oswestry Spinal Risk Index (OSRI) in an external population. The OSRI predicts survival in patients with metastatic spinal cord compression (MSCC).
A Leithner, A. Tambe, B Balain, C Wibmer, CS Lee, DA Karnofsky, HC Bauer, I Laufer, Irfan Siddique, J. Gregory, J. Stephenson, K Tomita, Mohammad Saeed, NA Quraishi, P Paholpak, PS Rose, R. Verma, S Yang, S. Whitehouse, V. Sinclair, Y Tokuhashi, Y Tokuhashi   +21 more
core   +1 more source

EANM guidelines for radionuclide therapy of bone metastases with beta-emitting radionuclides

European Journal of Nuclear Medicine and Molecular Imaging, 2018
The skeleton is the most common metastatic site in patients with advanced cancer. Pain is a major healthcare problem in patients with bone metastases.
D. Handkiewicz-Junak, T. Poeppel, L. Bodei, C. Aktolun, S. Ezziddin, F. Giammarile, R. Delgado-Bolton, M. Gabriel   +7 more
semanticscholar   +1 more source

Concomitant oral tyrosine kinase inhibitors and bisphosphonates in advanced renal cell carcinoma with bone metastases [PDF]

, 2012
Benoit Beuselinck, Pascal Wolter, Alexandra Karadimou, Réza Elaidi, Herlinde Dumez, Anne Rogiers, Thomas Van Cann, Ludo Willems, J.J. Body, J. Berkers, Hendrik Van Poppel, Evelyne Lerut, Philip R. Debruyne, Robert Paridaens, Patrick Schöffski   +14 more
openalex   +1 more source

Whole-Body MRI with Diffusion-Weighted Imaging in Bone Metastases: A Narrative Review

Diagnostics, 2018
Whole body magnetic resonance imaging (MRI) with diffusion-weighted imaging (WB-MRI-DWI) is currently emerging as a diagnostic technique in the evaluation of bone metastases from breast, prostate, lung, thyroid, and melanoma tumors.
A. Stecco, Alessandra Trisoglio, Eleonora Soligo, S. Berardo, Lidiia Sukhovei, A. Carriero   +5 more
semanticscholar   +1 more source